Bensheim, Germany, 20 June 2024 – The leading European manufacturer and developer of Cannabis-based medicines Avextra AG (“Avextra”), is proud to announce a strategic partnership in drug development with SynQube GmbH based in Offenbach, Germany. SynQube GmbH is led by the founders of THC Pharm Christian Steup and Holger Rönitz, both pioneers in cannabinoid therapy in Europe with over 25 years of experience in pharmaceutical development and manufacturing of cannabinoid and other psychotropic substances.

Read more